Photo courtesy of Allianz Global

Allianz Global announces new CFO for corporate and specialty

Claire-Marie Coste-Lepoutre will take over Oskar Buchauer.

Allianz Global Corporate and Specialty SE (AGCS) has named Oskar Buchauer as its new chief financial officer (CFO), beginning 1 September.

Claire-Marie Coste-Lepoutre, who has been AGCS' CFO for over four years, will take over Buchauer's current role of head of Allianz Group Actuarial, Planning and Controlling and Group Chief Actuary at Allianz SE.

ALSO READ: NEXEA allies with Allianz, Exitra, Spritzer for start-up support

In this role, she will collaborate closely with Allianz Group CFO Giulio Terzariol to oversee key strategic and financial functions across all divisions of the Allianz Group: Property/Casualty Insurance (P&C), Life/Health Insurance, and Asset Management.

Buchauer, on the other hand, will take on the role of CFO at AGCS during a transformative period, as Allianz Commercial and Allianz OEs globally enter a new phase of collaboration to establish a strong presence in the Commercial P&C segment (Mid Corp, Large Corp, and Specialty). 

He will assume direct responsibility for Finance on the Board of AGCS SE, which includes Accounting, Treasury & Tax, Actuarial, Compliance, Finance Solutions, Global Performance Steering, and Risk Management.

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.